世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

デュアルオレキシン受容体拮抗薬の世界市場インサイト、2031年までの予測

デュアルオレキシン受容体拮抗薬の世界市場インサイト、2031年までの予測


Global Dual Orexin Receptor Antagonist Market Insights, Forecast to 2031

デュアルオレキシン受容体拮抗薬の世界市場は、2024年の6億7,085万米ドルから2031年には12億3,497万米ドルに成長すると予測され、予測期間中の年間平均成長率(CAGR)は7.14%である。 デュアルオレキシン受容体... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年4月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

デュアルオレキシン受容体拮抗薬の世界市場は、2024年の6億7,085万米ドルから2031年には12億3,497万米ドルに成長すると予測され、予測期間中の年間平均成長率(CAGR)は7.14%である。
デュアルオレキシン受容体拮抗薬の米国・カナダ市場は、2024年の1億4,576万ドルから2031年には1億6,232万ドルに達すると推定され、2025年から2031年までの予測期間中のCAGRは0.61%である。
デュアルオレキシン受容体拮抗薬の日本市場は、2024年の4億3,187万ドルから2031年には7億7,711万ドルに達すると推定され、2025年から2031年までの予測期間中のCAGRは5.18%である。
デュアルオレキシン受容体拮抗薬の欧州市場は、2025年から2031年までの予測期間中に18.23%のCAGRで、2024年に7,935万ドルから増加し、2031年には3億4,307万ドルに達すると推定される。
デュアルオレキシン受容体拮抗薬の世界の主要メーカーには、Merck社、Eisal社、Idorsia社などがあります。2024年、世界の上位2社の売上高シェアは約83.43%であった。

レポートの内容
本レポートでは、デュアルオレキシン受容体拮抗薬の世界市場概要、売上高、価格を紹介しています。2020年~2024年の過去の市場収益/売上データ、2025年の予測、2031年までのCAGR予測による世界市場動向の分析。
本レポートでは、デュアルオレキシン受容体拮抗薬の主要生産者を調査し、主要地域・国の売上高も掲載しています。デュアルオレキシン受容体拮抗薬の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2020年から2024年までのデータについて、主要メーカーのデュアルオレキシン受容体拮抗薬の売上高、収益、市場シェア、業界ランキングに焦点を当てています。世界のデュアルオレキシン受容体拮抗薬市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2020年から2031年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。デュアルオレキシン受容体拮抗薬(Dual Orexin Receptor Antagonist)の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
Merck、Eisal、Idorsiaなど、世界の主要企業の詳細な企業プロフィール。

市場セグメンテーション

企業別
メルク
アイザル
イドルシア

タイプ別
スボレキサント
レンボレキサント
ダリドレキサント

用途別セグメント
病院・診療所
小売薬局
その他

地域別セグメント
米国・カナダ
米国
カナダ
欧州
日本

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 デュアルオレキシン受容体拮抗薬の世界、地域レベル、国レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。
第3章 デュアルオレキシン受容体拮抗薬メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの売上高、収益、平均価格、発展可能性などを網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ:タイプ別、用途別、セグメント別の売上高、収益
第8章:日本:タイプ別、用途別、セグメント別の売上高と収益。
第9章:ROW:タイプ別、用途別、セグメント別の売上高と収益。
第10章:主要メーカーのプロファイルを提供し、製品の説明や仕様、デュアルオレキシン受容体拮抗薬の売上高、収益、価格、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第11章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第12章:市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第13章:レポートの要点と結論。

ページTOPに戻る


目次

1 STUDY COVERAGE 1
1.1 Dual Orexin Receptor Antagonist Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 1
1.2.2 Suvorexant 3
1.2.3 Lemborexant 4
1.2.4 Daridorexant 5
1.3 Market by Application 6
1.3.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 6
1.3.2 Hospital and Clinic 8
1.3.3 Retail Pharmacies 9
1.3.4 Other 9
1.4 Assumptions and Limitations 10
1.5 Study Objectives 11
1.6 Years Considered 12
2 EXECUTIVE SUMMARY 13
2.1 Global Dual Orexin Receptor Antagonist Revenue Estimates and Forecasts 2020-2031 13
2.2 Global Revenue by Region 14
2.2.1 Global Dual Orexin Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031 14
2.2.2 Global Dual Orexin Receptor Antagonist Revenue by Region (2020-2031) 17
2.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2031) 17
2.3 Global Dual Orexin Receptor Antagonist Sales Estimates and Forecasts 2020-2031 19
2.4 Global Sales by Region 19
2.4.1 Global Dual Orexin Receptor Antagonist Sales by Region: 2020 VS 2024 VS 2031 19
2.4.2 Global Dual Orexin Receptor Antagonist Sales by Region (2020-2031) 20
2.4.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2031) 21
2.5 US & Canada 23
2.6 Europe 24
2.7 Japan 25
2.8 ROW 26
3 COMPETITION BY MANUFACTURERS 27
3.1 Global Sales by Manufacturers 27
3.1.1 Global Dual Orexin Receptor Antagonist Sales by Manufacturers (2020-2025) 27
3.1.2 Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2020-2025) 28
3.1.3 Global Top 3 Largest Manufacturers of Dual Orexin Receptor Antagonist in 2024 28
3.2 Global Revenue by Manufacturers 29
3.2.1 Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (2020-2025) 29
3.2.2 Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025) 30
3.2.3 Global Top 2 Companies by Dual Orexin Receptor Antagonist Revenue in 2024 31
3.3 Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2023 VS 2024 31
3.4 Global Dual Orexin Receptor Antagonist Sales Price by Manufacturers (2020-2025) 32
3.5 Analysis of Competitive Landscape 32
3.5.1 Manufacturers Market Concentration Ratio (CR3 and HHI) 32
3.5.2 Global Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 33
3.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Base Distribution and Headquarters 35
3.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Offered and Application 35
3.8 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry 36
3.9 Mergers & Acquisitions, Expansion Plans 36
4 MARKET SIZE BY TYPE 38
4.1 Global Sales by Type 38
4.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Type (2020-2025) 38
4.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Type (2026-2031) 38
4.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031) 39
4.2 Global Revenue by Type 40
4.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Type (2020-2025) 40
4.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Type (2026-2031) 41
4.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031) 41
4.3 Global Price by Type 42
4.3.1 Global Dual Orexin Receptor Antagonist Price by Type (2020-2025) 42
4.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Type (2026-2031) 43
5 MARKET SIZE BY APPLICATION 44
5.1 Global Sales by Application 44
5.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Application (2020-2025) 44
5.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Application (2026-2031) 44
5.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031) 45
5.2 Global Revenue by Application 46
5.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Application (2020-2025) 46
5.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Application (2026-2031) 47
5.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031) 47
5.3 Global Price by Application 48
5.3.1 Global Dual Orexin Receptor Antagonist Price by Application (2020-2025) 48
5.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Application (2026-2031) 49
6 US & CANADA 50
6.1 US & Canada Market Size by Type 50
6.1.1 US & Canada Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 50
6.1.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 51
6.2 US & Canada Market Size by Application 52
6.2.1 US & Canada Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 52
6.2.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 54
6.3 US & Canada Market Size by Country 55
6.3.1 US & Canada Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 55
6.3.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Country (2020-2031) 56
6.3.3 US & Canada Dual Orexin Receptor Antagonist Sales by Country (2020-2031) 57
6.3.4 US 58
6.3.5 Canada 59
7 EUROPE 60
7.1 Europe Market Size by Type 60
7.1.1 Europe Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 60
7.1.2 Europe Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 60
7.2 Europe Market Size by Application 61
7.2.1 Europe Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 61
7.2.2 Europe Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 62
8 JAPAN 64
8.1 Japan Market Size by Type 64
8.1.1 Japan Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 64
8.1.2 Japan Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 65
8.2 Japan Market Size by Application 66
8.2.1 Japan Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 66
8.2.2 Japan Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 68
9 ROW 70
9.1 ROW Market Size by Type 70
9.1.1 ROW Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 70
9.1.2 ROW Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 70
9.2 ROW Market Size by Application 71
9.2.1 ROW Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 71
9.2.2 ROW Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 72
10 CORPORATE PROFILE 74
10.1 Merck 74
10.1.1 Merck Company Information 74
10.1.2 Merck Overview 74
10.1.3 Merck Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025) 75
10.1.4 Merck Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications 75
10.1.5 Merck Recent Developments 76
10.2 Eisal 76
10.2.1 Eisal Company Information 76
10.2.2 Eisal Overview 77
10.2.3 Eisal Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025) 77
10.2.4 Eisal Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications 78
10.2.5 Eisal Recent Developments 78
10.3 Idorsia 79
10.3.1 Idorsia Company Information 79
10.3.2 Idorsia Overview 79
10.3.3 Idorsia Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025) 80
10.3.4 Idorsia Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications 80
10.3.5 Idorsia Recent Developments 81
11 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 82
11.1 Dual Orexin Receptor Antagonist Industry Chain Analysis 82
11.2 Dual Orexin Receptor Antagonist Key Raw Materials 82
11.2.1 Key Raw Materials 82
11.2.2 Raw Materials Key Suppliers 83
11.3 Dual Orexin Receptor Antagonist Production Mode & Process 83
11.4 Dual Orexin Receptor Antagonist Sales and Marketing 84
11.4.1 Dual Orexin Receptor Antagonist Sales Channels 84
11.4.2 Dual Orexin Receptor Antagonist Distributors 84
11.5 Dual Orexin Receptor Antagonist Customers 85
12 DUAL OREXIN RECEPTOR ANTAGONIST MARKET DYNAMICS 86
12.1.1 Dual Orexin Receptor Antagonist Industry Trends 86
12.1.2 Dual Orexin Receptor Antagonist Market Drivers 87
12.1.3 Dual Orexin Receptor Antagonist Market Challenges 87
12.1.4 Dual Orexin Receptor Antagonist Market Restraints 88
13 KEY FINDINGS IN THE GLOBAL DUAL OREXIN RECEPTOR ANTAGONIST STUDY 89
14 APPENDIX 90
14.1 Research Methodology 90
14.1.1 Methodology/Research Approach 90
14.1.2 Data Source 93
14.2 Author Details 95
14.3 Disclaimer 96

 

ページTOPに戻る


 

Summary

The global Dual Orexin Receptor Antagonist market is projected to grow from US$ 670.85 million in 2024 to US$ 1,234.97 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.14% during the forecast period.
The United States & Canada market for Dual Orexin Receptor Antagonist is estimated to increase from $ 145.76 million in 2024 to reach $162.32 million by 2031, at a CAGR of 0.61% during the forecast period of 2025 through 2031.
The Japan market for Dual Orexin Receptor Antagonist is estimated to increase from $ 431.87 million in 2024 to reach $707.11 million by 2031, at a CAGR of 5.18% during the forecast period of 2025 through 2031.
The Europe market for Dual Orexin Receptor Antagonist is estimated to increase from $ 79.35 million in 2024 to reach $343.07 million by 2031, at a CAGR of 18.23% during the forecast period of 2025 through 2031.
The global key manufacturers of Dual Orexin Receptor Antagonist include Merck, Eisal, Idorsia, etc. In 2024, the global top two players had a share approximately 83.43% in terms of revenue.

Report Includes
This report presents an overview of global market for Dual Orexin Receptor Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Dual Orexin Receptor Antagonist, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dual Orexin Receptor Antagonist, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dual Orexin Receptor Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2024. Identification of the major stakeholders in the global Dual Orexin Receptor Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dual Orexin Receptor Antagonist sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Eisal, Idorsia, etc.

Market Segmentation

By Company
Merck
Eisal
Idorsia

Segment by Type
Suvorexant
Lemborexant
Daridorexant

Segment by Application
Hospital and Clinic
Retail Pharmacies
Other

Segment by Region
US & Canada
U.S.
Canada
Europe
Japan

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dual Orexin Receptor Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dual Orexin Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, and by Application, sales, and revenue for each segment.
Chapter 8: Japan by Type, and by Application, sales, and revenue for each segment.
Chapter 9: ROW by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dual Orexin Receptor Antagonist sales, revenue, price, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 STUDY COVERAGE 1
1.1 Dual Orexin Receptor Antagonist Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 1
1.2.2 Suvorexant 3
1.2.3 Lemborexant 4
1.2.4 Daridorexant 5
1.3 Market by Application 6
1.3.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 6
1.3.2 Hospital and Clinic 8
1.3.3 Retail Pharmacies 9
1.3.4 Other 9
1.4 Assumptions and Limitations 10
1.5 Study Objectives 11
1.6 Years Considered 12
2 EXECUTIVE SUMMARY 13
2.1 Global Dual Orexin Receptor Antagonist Revenue Estimates and Forecasts 2020-2031 13
2.2 Global Revenue by Region 14
2.2.1 Global Dual Orexin Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031 14
2.2.2 Global Dual Orexin Receptor Antagonist Revenue by Region (2020-2031) 17
2.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2031) 17
2.3 Global Dual Orexin Receptor Antagonist Sales Estimates and Forecasts 2020-2031 19
2.4 Global Sales by Region 19
2.4.1 Global Dual Orexin Receptor Antagonist Sales by Region: 2020 VS 2024 VS 2031 19
2.4.2 Global Dual Orexin Receptor Antagonist Sales by Region (2020-2031) 20
2.4.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2031) 21
2.5 US & Canada 23
2.6 Europe 24
2.7 Japan 25
2.8 ROW 26
3 COMPETITION BY MANUFACTURERS 27
3.1 Global Sales by Manufacturers 27
3.1.1 Global Dual Orexin Receptor Antagonist Sales by Manufacturers (2020-2025) 27
3.1.2 Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2020-2025) 28
3.1.3 Global Top 3 Largest Manufacturers of Dual Orexin Receptor Antagonist in 2024 28
3.2 Global Revenue by Manufacturers 29
3.2.1 Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (2020-2025) 29
3.2.2 Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025) 30
3.2.3 Global Top 2 Companies by Dual Orexin Receptor Antagonist Revenue in 2024 31
3.3 Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2023 VS 2024 31
3.4 Global Dual Orexin Receptor Antagonist Sales Price by Manufacturers (2020-2025) 32
3.5 Analysis of Competitive Landscape 32
3.5.1 Manufacturers Market Concentration Ratio (CR3 and HHI) 32
3.5.2 Global Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 33
3.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Base Distribution and Headquarters 35
3.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Offered and Application 35
3.8 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry 36
3.9 Mergers & Acquisitions, Expansion Plans 36
4 MARKET SIZE BY TYPE 38
4.1 Global Sales by Type 38
4.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Type (2020-2025) 38
4.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Type (2026-2031) 38
4.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031) 39
4.2 Global Revenue by Type 40
4.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Type (2020-2025) 40
4.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Type (2026-2031) 41
4.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031) 41
4.3 Global Price by Type 42
4.3.1 Global Dual Orexin Receptor Antagonist Price by Type (2020-2025) 42
4.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Type (2026-2031) 43
5 MARKET SIZE BY APPLICATION 44
5.1 Global Sales by Application 44
5.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Application (2020-2025) 44
5.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Application (2026-2031) 44
5.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031) 45
5.2 Global Revenue by Application 46
5.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Application (2020-2025) 46
5.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Application (2026-2031) 47
5.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031) 47
5.3 Global Price by Application 48
5.3.1 Global Dual Orexin Receptor Antagonist Price by Application (2020-2025) 48
5.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Application (2026-2031) 49
6 US & CANADA 50
6.1 US & Canada Market Size by Type 50
6.1.1 US & Canada Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 50
6.1.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 51
6.2 US & Canada Market Size by Application 52
6.2.1 US & Canada Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 52
6.2.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 54
6.3 US & Canada Market Size by Country 55
6.3.1 US & Canada Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 55
6.3.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Country (2020-2031) 56
6.3.3 US & Canada Dual Orexin Receptor Antagonist Sales by Country (2020-2031) 57
6.3.4 US 58
6.3.5 Canada 59
7 EUROPE 60
7.1 Europe Market Size by Type 60
7.1.1 Europe Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 60
7.1.2 Europe Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 60
7.2 Europe Market Size by Application 61
7.2.1 Europe Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 61
7.2.2 Europe Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 62
8 JAPAN 64
8.1 Japan Market Size by Type 64
8.1.1 Japan Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 64
8.1.2 Japan Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 65
8.2 Japan Market Size by Application 66
8.2.1 Japan Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 66
8.2.2 Japan Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 68
9 ROW 70
9.1 ROW Market Size by Type 70
9.1.1 ROW Dual Orexin Receptor Antagonist Sales by Type (2020-2031) 70
9.1.2 ROW Dual Orexin Receptor Antagonist Revenue by Type (2020-2031) 70
9.2 ROW Market Size by Application 71
9.2.1 ROW Dual Orexin Receptor Antagonist Sales by Application (2020-2031) 71
9.2.2 ROW Dual Orexin Receptor Antagonist Revenue by Application (2020-2031) 72
10 CORPORATE PROFILE 74
10.1 Merck 74
10.1.1 Merck Company Information 74
10.1.2 Merck Overview 74
10.1.3 Merck Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025) 75
10.1.4 Merck Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications 75
10.1.5 Merck Recent Developments 76
10.2 Eisal 76
10.2.1 Eisal Company Information 76
10.2.2 Eisal Overview 77
10.2.3 Eisal Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025) 77
10.2.4 Eisal Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications 78
10.2.5 Eisal Recent Developments 78
10.3 Idorsia 79
10.3.1 Idorsia Company Information 79
10.3.2 Idorsia Overview 79
10.3.3 Idorsia Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025) 80
10.3.4 Idorsia Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications 80
10.3.5 Idorsia Recent Developments 81
11 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 82
11.1 Dual Orexin Receptor Antagonist Industry Chain Analysis 82
11.2 Dual Orexin Receptor Antagonist Key Raw Materials 82
11.2.1 Key Raw Materials 82
11.2.2 Raw Materials Key Suppliers 83
11.3 Dual Orexin Receptor Antagonist Production Mode & Process 83
11.4 Dual Orexin Receptor Antagonist Sales and Marketing 84
11.4.1 Dual Orexin Receptor Antagonist Sales Channels 84
11.4.2 Dual Orexin Receptor Antagonist Distributors 84
11.5 Dual Orexin Receptor Antagonist Customers 85
12 DUAL OREXIN RECEPTOR ANTAGONIST MARKET DYNAMICS 86
12.1.1 Dual Orexin Receptor Antagonist Industry Trends 86
12.1.2 Dual Orexin Receptor Antagonist Market Drivers 87
12.1.3 Dual Orexin Receptor Antagonist Market Challenges 87
12.1.4 Dual Orexin Receptor Antagonist Market Restraints 88
13 KEY FINDINGS IN THE GLOBAL DUAL OREXIN RECEPTOR ANTAGONIST STUDY 89
14 APPENDIX 90
14.1 Research Methodology 90
14.1.1 Methodology/Research Approach 90
14.1.2 Data Source 93
14.2 Author Details 95
14.3 Disclaimer 96

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(receptor)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/07 10:26

146.78 円

161.35 円

192.22 円

ページTOPに戻る